Outpatient Laboratory Monitoring for Antibiotic-related Adverse Events in Children With Acute Hematogenous Osteomyelitis

Felicia O. Rosiji,Marritta Joseph,Lauren M. Sommer,Sheldon L. Kaplan,Jesus G. Vallejo,J. Chase McNeil
DOI: https://doi.org/10.1097/inf.0000000000004576
2024-09-30
Abstract:Monitoring for antibiotic-related lab abnormalities (ARLA), including hematologic, renal, and/or hepatic toxicity, in pediatric osteomyelitis is common. In 240 cases of osteomyelitis with outpatient laboratory monitoring, ARLA occurred in 13.3% with the most common finding being neutropenia. ARLA impacted antibiotic therapy in <1% of subjects, however, raising questions about the value of such monitoring being performed routinely.
pediatrics,immunology,infectious diseases
What problem does this paper attempt to address?